Q3 2023 13F Holders as of 9/30/2023
-
Type / Class
-
Equity / Class A Common Stock, par value $0.01 per share
-
Shares outstanding
-
117M
-
Number of holders
-
198
-
Total 13F shares, excl. options
-
121M
-
Shares change
-
+5.11M
-
Total reported value, excl. options
-
$3.32B
-
Value change
-
+$134M
-
Put/Call ratio
-
3.32
-
Number of buys
-
96
-
Number of sells
-
-101
-
Price
-
$27.23
Significant Holders of Evolent Health, Inc. - Class A Common Stock, par value $0.01 per share (EVH) as of Q3 2023
240 filings reported holding EVH - Evolent Health, Inc. - Class A Common Stock, par value $0.01 per share as of Q3 2023.
Evolent Health, Inc. - Class A Common Stock, par value $0.01 per share (EVH) has 198 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 121M shares
.
Largest 10 shareholders include FMR LLC (16.5M shares), VANGUARD GROUP INC (10.6M shares), BlackRock Inc. (7.84M shares), JPMORGAN CHASE & CO (6.05M shares), WELLINGTON MANAGEMENT GROUP LLP (4.24M shares), Rock Springs Capital Management LP (3.87M shares), Bellevue Group AG (3.68M shares), Granahan Investment Management, LLC (2.95M shares), ORBIMED ADVISORS LLC (2.9M shares), and BLAIR WILLIAM & CO/IL (2.85M shares).
This table shows the top 198 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.